COMPANY · NIPC 509264662

Shire Pharmaceuticals Portugal, Lda.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €71,265,778.65 across 378 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameShire Pharmaceuticals Portugal, Lda.
NIPC509264662

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2020. The table below gives the same values.2012: €1,338,514.0920122013: €3,150,156.332014: €6,656,727.8820142015: €8,644,819.712016: €1,323,977.0820162017: €3,428,236.042018: €17,131,448.2720182019: €25,085,085.852020: €4,506,813.402020€25,085,085.85
Contracted value by year
YearContractsContract value
201213€1,338,514.09
201333€3,150,156.33
201428€6,656,727.88
201531€8,644,819.71
201624€1,323,977.08
201742€3,428,236.04
2018101€17,131,448.27
201976€25,085,085.85
202030€4,506,813.40
Contracted value by place of performance
NameContractsContract value
Lisboa142€25,569,315.43
Coimbra47€23,612,184.53
Faro43€6,098,413.22
Porto13€4,163,067.40
Vila Nova de Gaia30€1,609,893.94
Évora11€1,225,108.71
Funchal9€393,450.50
Santa Maria da Feira3€263,677.06
Bragança2€259,534.75
Setúbal7€246,677.04
Largest contracts
SubjectYearContract value
CPA 2013/50 - Medicamentos de consumo geral; medicamentos antialergicos; medicamentos usados no tratamento de intoxicação e grupo 20.92014€5,525,819.96
Medicamentos de consumo geral, medicação anti-alérgina, tratamento de intoxicações - C/ Base no CPA 2013/502015€4,903,295.61
P259-2018-168 - Aquisição de medicamentos para Doenças Lisossomais de Sobrecarga ao abrigo do AQ 2017/58 para as instituições do SNS2019€2,964,004.12
51004320 - AQUISIÇÃO DE DIVERSOS MEDICAMENTOS PARA DOENÇAS LISOSSOMAIS - P259-2019-1922019€2,873,676.60
P259-2018-168 - Aquisição de medicamentos para Doenças Lisossomais de Sobrecarga ao abrigo do AQ 2017/58 para as instituições do SNS2019€2,441,088.60

Who they competed with

In 442 contracts with a list of competitors, the company took part and was awarded 69 (16%).

Companies with the most procedures in common
CompanyProcedures in common
Teva Pharma25
Generis-Farmacêutica, S.A.25
accord23
logifarma20
Fresenius kabi18
Pfizer17
TECNIMEDE (FARMOZ)16
Baxter Médico Farmacêutica, Lda.14
Unilfarma, Lda.12
Hikma Farmacêutica, Lda.12
labesfal, sa11
B.Braun11
bfph11
Mylan, Lda.10
Overpharma, Produtos Médicos e Farmacêuticos, Lda.10
Merck, Sharp & Dohme, Lda.9
Logista e Pharma, Lda.9
Sanofi, Lda.8
Roche-Farmacêutica Química, Lda.8
Csl Behring, Unipessoal Lda8
dla sa8
Abbvie Lda8
Pfizer Biofarmacêutica, Soc. Unipessoal, Lda.8
SHIRE PHARMACEUTICALS PORTUGAL, LDA7
Takeda Farmacêutica Portugal, Lda7
Laboratórios Normon7
VIIVHIV HEALTHCARE, UNIPESSOAL. LDA7
Medac Sucursal em Portugal7
GlaxoSmithKline - Produtos Farmacêuticos, Lda6
lilly6

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents40 companies and 60 links. The list below gives the same content as text.SHIRE PHARMACE… (NIPC 500063524)SHIRE PHARMACE…Sanofi, Lda. (NIPC 500134960)Sanofi, Lda.Pfizer (NIPC 500162166)PfizerMerck, Sharp &… (NIPC 500191360)Merck, Sharp &…Roche-Farmacêu… (NIPC 500233810)Roche-Farmacêu…Unilfarma, Lda. (NIPC 500293023)Unilfarma, Lda.labesfal, sa (NIPC 501169580)labesfal, saTECNIMEDE (FAR… (NIPC 501505334)TECNIMEDE (FAR…B.Braun (NIPC 501506543)B.BraunHikma Farmacêu… (NIPC 502266791)Hikma Farmacêu…NIPC 509264662 (NIPC 509264662)NIPC 509264662+29 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.